COLL
COLL
NASDAQ · Pharmaceuticals

Collegium Pharmaceutical Inc

$29.47
+0.36 (+1.24%)
As of Aug 8, 10:08 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +63.4% upside
Low Target $33.48
Average Target $48.15
High Target $61.72
Current Price $29.47
Current
$29.47
Target
$48.15
$33.48 $48.15 avg $61.72
Scenario Analysis
Bear Case
$33.48
13.6%
Low target
Base Case
$48.15
+63.4%
Avg target
Bull Case
$61.72
+109.4%
High target
Risk/Reward
8.0x
Highly favorable
Price in Context
52-Week High
$50.79
-42.0% from high
52-Week Low
$28.90
+2.0% from low
Target vs 52W High
$48.15
-5.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%